Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
5.81T | 5.75T | 5.67T | 5.45T | 5.31T | 5.24T | Gross Profit |
2.46T | 2.43T | 2.41T | 2.46T | 2.38T | 2.31T | EBIT |
957.91B | 961.58B | 1.08T | 1.06T | 1.04T | 1.03T | EBITDA |
1.63T | 1.62T | 1.71T | 1.78T | 1.76T | 1.71T | Net Income Common Stockholders |
637.88B | 637.87B | 679.11B | 672.49B | 651.50B | 639.77B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.47T | 887.21B | 844.97B | 1.12T | 1.11T | 639.16B | Total Assets |
15.64T | 14.15T | 11.92T | 11.08T | 10.54T | 9.58T | Total Debt |
3.39T | 2.43T | 1.65T | 1.74T | 1.76T | 1.75T | Net Debt |
1.92T | 1.55T | 1.17T | 944.84B | 951.49B | 1.38T | Total Liabilities |
9.84T | 8.35T | 6.25T | 5.57T | 5.28T | 4.72T | Stockholders Equity |
5.27T | 5.25T | 5.12T | 4.98T | 4.76T | 4.38T |
Cash Flow | Free Cash Flow | ||||
1.51T | 956.97B | 444.74B | 793.08B | 1.06T | 704.05B | Operating Cash Flow |
2.22T | 1.71T | 1.08T | 1.47T | 1.68T | 1.32T | Investing Cash Flow |
-1.29T | -832.43B | -732.48B | -761.59B | -658.92B | -610.95B | Financing Cash Flow |
49.08B | -476.48B | -669.84B | -727.26B | -585.57B | -546.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $17.05B | 12.17 | 16.28% | 6.18% | -5.14% | -7.47% | |
76 Outperform | $34.98B | 29.72 | 9.59% | 3.32% | -0.19% | -0.79% | |
71 Outperform | $24.26B | 9.21 | -7.17% | 5.16% | -24.84% | -74.77% | |
71 Outperform | $51.98B | 31.28 | 8.54% | 2.83% | 0.19% | -49.68% | |
64 Neutral | $64.06B | 15.15 | 13.04% | 1.86% | -5.67% | -11.74% | |
64 Neutral | $30.06B | ― | -0.55% | 5.99% | 1.18% | ― | |
61 Neutral | $14.64B | 5.81 | -3.99% | 6.03% | 2.71% | -31.56% |